A Trial of FANG™ Vaccine for Participants With Ovarian Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John Nemunaitis, MD
Gradalis, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Florida Cancer Specialists
West Palm Beach, Florida, United States
- Dartmouth-Hitchcock Medical Center/norris Cotton Cancer Center
Lebanon, New Hampshire, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Mary Crowley Cancer Research Centers
Dallas, Texas, United States
- Texas Oncology - Sammons Cancer Center
Dallas, Texas, United States
- Texas Oncology - Fort Worth
Fort Worth, Texas, United States
- Cancer Care Northwest
Spokane, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Mar 2011
- Primary completion
- 2 Feb 2022
- Completion
- 2 Feb 2022
- Last update posted
- 8 Jun 2025
- Registered enrollment
- 39
- Registry id
- NCT01309230
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.